User menu

A single dose of zoledronic acid 5mg achieves more sustained biochemical remission versus daily 30mg risedronate in patients with Paget's disease

Bibliographic reference Reid, I. ; Devogelaer, Jean-Pierre ; Miller, P. ; Brown, J. ; Fraser, W. ; et. al. A single dose of zoledronic acid 5mg achieves more sustained biochemical remission versus daily 30mg risedronate in patients with Paget's disease.11th Conference of the National-Osteoporosis-Society (Harrogate (England), Jun 25-28, 2006). In: Osteoporosis International : with other metabolic bone diseases, Vol. 17, p. S31-S31 (2006)
Permanent URL http://hdl.handle.net/2078.1/59403